Spotlight Therapeutics
Spotlight Therapeutics is a developer of gene editing therapeutics intended to edit specific cell populations directly in the body. The company's therapeutics are used to create next-generation programmable nucleases that can selectively target and edit cells, enabling physicians to treat their patient in an enhanced way.
View Top Employees for Spotlight Therapeutics
|
Website | spotlighttx.com |
|
Industry | Biotechnology |
|
Location | Hayward, California, United States |
|
Employees | 21 |
|
Founded | 2017 |
|
HQ | 26118 Research Place |
|
Funding | 80,666,664 USD |
|
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
|
|
Website | spotlighttx.com |
|
|
Industry | Biotechnology |
|
|
Location | Hayward, California, United States |
|
|
Employees | 21 |
|
|
Founded | 2017 |
|
linkedin.com/company/spotlighttx | |
|
|
HQ | 26118 Research Place |
|
|
Funding | 80,666,664 USD |
Email Patterns for Spotlight Therapeutics
Top Competitors for Spotlight Therapeutics
Spotlight Therapeutics Questions
Where are Spotlight Therapeutics's headquarters?
Spotlight Therapeutics's headquarters are in 26118 Research Place
What is Spotlight Therapeutics's official website?
Spotlight Therapeutics's website is spotlighttx.com
How many employees are working in Spotlight Therapeutics right now?
Spotlight Therapeutics has
21 employees.
View the Email and Phone Numbers for all 21 working at Spotlight Therapeutics.
What is Spotlight Therapeutics's industry?
Spotlight Therapeutics's industry is
Biotechnology
Who are Spotlight Therapeutics's top competitors?
Spotlight Therapeutics's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What are Spotlight Therapeutics's categories?
Spotlight Therapeutics's categories are Biotechnology, Health Care, Life Science, Therapeutics
What is Spotlight Therapeutics's location?
Spotlight Therapeutics's location is
Hayward, California, United States
When was Spotlight Therapeutics's founded?
Spotlight Therapeutics's founding year is 2017
What is Spotlight Therapeutics's funding?
Spotlight Therapeutics's funding is 80,666,664 USD
What is Spotlight Therapeutics's current status?
Spotlight Therapeutics's current status is operating
Top Spotlight Therapeutics Employees
Research Associate
srmccawley@gmail.com
+1713-818-1778
Scientist I Gene Editing
rina.mepani@gmail.com
+1617-972-3720
Scientist Ii
aaron.cantor@berkeley.edu
+1907-477-0453
Research Associate
+1530-761-6410
President, Chief Executive Officer And Board Member
mhaakfrendscho@bluelinebio.com
+1650-697-4900
Executive Administrator And Office Manager
Research Associate Ii
